CTI Biopharma reported $1.2B in Market Capitalization this June of 2023, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Baxter International USD 8.67B 1.15B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Geron USD 967M 124M May/2026
Incyte USD 21.73B 3B May/2026
Northwest Biotherapeutics USD 236M 120M May/2026
Novartis USD 232.75B 75B May/2026
Plus Therapeutics USD 71M 19M Dec/2025